FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118407508> ?p ?o ?g. }

• W2118407508 endingPage "813" @default.
• W2118407508 startingPage "808" @default.
• W2118407508 abstract "We attempted to induce anti-tumour immunity for rejecting pre-B lymphoma derived from E mu/ret transgenic mice (TGM). We established pre-B-lymphoma cell lines of C57BL/6 x Balb/c background (H-2b/d) into which H-2k alloantigen and C3H background were introduced (retL1-6 and retL6-6), and we inoculated BCF1 mice with these immunising tumour cells. After these tumours were rejected by alloantigen (H-2k/C3H background)-specific effector cells, the mice were challenged with the pre-B-lymphoma cell line derived from the original E mu/ret TGM (ret0-2). All non-immunised control mice died within 80 days, whereas half the immunised mice survived for over 300 days. The immunity was also effective against primary pre-B-lymphoma cells from E mu/ret TGM and the ret-driven melanoma cell line (MEL-ret), but not against the pre-B-lymphoma cell line from E mu/myc TGM. This immunity was at least in part mediated by cell-mediated cytotoxicity that was specific to the ret oncogene product or ret-regulated antigen. Next we immunised E mu/ret TGM by inoculating them with retL6-6 cells once every 2 weeks beginning at the age of 1 month. Interestingly, this immunisation enabled the TGM to survive longer than the non-immunised control group (P < 0.05). Moreover, 2 of 11 transgenic mice receiving such immunisation were free from both macroscopic and microscopic tumours at the time when all of the 12 non-immunised control TGM had died from their tumour. This provides a new model for oncogene-linked immunotherapy research." @default.
• W2118407508 created "2016-06-24" @default.
• W2118407508 creator A5005418520 @default.
• W2118407508 creator A5006655348 @default.
• W2118407508 creator A5021188073 @default.
• W2118407508 creator A5032957217 @default.
• W2118407508 creator A5044404332 @default.
• W2118407508 creator A5046650162 @default.
• W2118407508 creator A5048038268 @default.
• W2118407508 creator A5051889254 @default.
• W2118407508 creator A5055649452 @default.
• W2118407508 creator A5089988781 @default.
• W2118407508 date "1995-04-01" @default.
• W2118407508 modified "2023-10-10" @default.
• W2118407508 title "Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in Eμ/ret transgenic mice" @default.
• W2118407508 cites W1541310872 @default.
• W2118407508 cites W1545495395 @default.
• W2118407508 cites W1556274289 @default.
• W2118407508 cites W1574892766 @default.
• W2118407508 cites W1629158872 @default.
• W2118407508 cites W1981004390 @default.
• W2118407508 cites W1996671893 @default.
• W2118407508 cites W2008564146 @default.
• W2118407508 cites W2011724423 @default.
• W2118407508 cites W2012141473 @default.
• W2118407508 cites W2019505133 @default.
• W2118407508 cites W2021920683 @default.
• W2118407508 cites W2030430017 @default.
• W2118407508 cites W2039723556 @default.
• W2118407508 cites W2041601304 @default.
• W2118407508 cites W2043732412 @default.
• W2118407508 cites W2044761914 @default.
• W2118407508 cites W2058980559 @default.
• W2118407508 cites W2103066464 @default.
• W2118407508 cites W2107403957 @default.
• W2118407508 cites W2114657480 @default.
• W2118407508 cites W2124578657 @default.
• W2118407508 cites W2140672059 @default.
• W2118407508 cites W2146309350 @default.
• W2118407508 cites W2159466351 @default.
• W2118407508 cites W2173997865 @default.
• W2118407508 cites W2277460059 @default.
• W2118407508 cites W2335005863 @default.
• W2118407508 cites W2399909885 @default.
• W2118407508 cites W2413198977 @default.
• W2118407508 cites W2416219867 @default.
• W2118407508 cites W4213384598 @default.
• W2118407508 cites W4253503664 @default.
• W2118407508 doi "https://doi.org/10.1038/bjc.1995.156" @default.
• W2118407508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2033753" @default.
• W2118407508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7710948" @default.
• W2118407508 hasPublicationYear "1995" @default.
• W2118407508 type Work @default.
• W2118407508 sameAs 2118407508 @default.
• W2118407508 citedByCount "5" @default.
• W2118407508 crossrefType "journal-article" @default.
• W2118407508 hasAuthorship W2118407508A5005418520 @default.
• W2118407508 hasAuthorship W2118407508A5006655348 @default.
• W2118407508 hasAuthorship W2118407508A5021188073 @default.
• W2118407508 hasAuthorship W2118407508A5032957217 @default.
• W2118407508 hasAuthorship W2118407508A5044404332 @default.
• W2118407508 hasAuthorship W2118407508A5046650162 @default.
• W2118407508 hasAuthorship W2118407508A5048038268 @default.
• W2118407508 hasAuthorship W2118407508A5051889254 @default.
• W2118407508 hasAuthorship W2118407508A5055649452 @default.
• W2118407508 hasAuthorship W2118407508A5089988781 @default.
• W2118407508 hasBestOaLocation W21184075081 @default.
• W2118407508 hasConcept C102230213 @default.
• W2118407508 hasConcept C104317684 @default.
• W2118407508 hasConcept C141035611 @default.
• W2118407508 hasConcept C147483822 @default.
• W2118407508 hasConcept C159047783 @default.
• W2118407508 hasConcept C159654299 @default.
• W2118407508 hasConcept C203014093 @default.
• W2118407508 hasConcept C2777257650 @default.
• W2118407508 hasConcept C2778453870 @default.
• W2118407508 hasConcept C2779338263 @default.
• W2118407508 hasConcept C2779341262 @default.
• W2118407508 hasConcept C502942594 @default.
• W2118407508 hasConcept C55493867 @default.
• W2118407508 hasConcept C71924100 @default.
• W2118407508 hasConcept C86803240 @default.
• W2118407508 hasConcept C8891405 @default.
• W2118407508 hasConceptScore W2118407508C102230213 @default.
• W2118407508 hasConceptScore W2118407508C104317684 @default.
• W2118407508 hasConceptScore W2118407508C141035611 @default.
• W2118407508 hasConceptScore W2118407508C147483822 @default.
• W2118407508 hasConceptScore W2118407508C159047783 @default.
• W2118407508 hasConceptScore W2118407508C159654299 @default.
• W2118407508 hasConceptScore W2118407508C203014093 @default.
• W2118407508 hasConceptScore W2118407508C2777257650 @default.
• W2118407508 hasConceptScore W2118407508C2778453870 @default.
• W2118407508 hasConceptScore W2118407508C2779338263 @default.
• W2118407508 hasConceptScore W2118407508C2779341262 @default.
• W2118407508 hasConceptScore W2118407508C502942594 @default.
• W2118407508 hasConceptScore W2118407508C55493867 @default.
• W2118407508 hasConceptScore W2118407508C71924100 @default.
• W2118407508 hasConceptScore W2118407508C86803240 @default.

• next